We are live on ! Find out more
HCC

Hirtle Callaghan & Co Portfolio holdings

AUM $2.92B
1-Year Est. Return 17.65%
This Fund
S&P 500
This Quarter Est. Return
+2.65%
1 Year Est. Return
+17.65%
3 Year Est. Return
+46.66%
5 Year Est. Return
+38.61%
10 Year Est. Return
+120.72%
AUM
$8.64M
AUM Growth
Cap. Flow
+$8.44M
Cap. Flow %
97.75%
Top 10 Hldgs %
59.99%
Holding
94
New
91
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Financials 19.6%
2 Technology 19.47%
3 Consumer Staples 16.95%
4 Healthcare 15.07%
5 Industrials 7.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PVFC
51
DELISTED
PVF CAPITAL CORP
PVFC
$1K 0.01%
+200
New +$761
CYTR
52
DELISTED
CytRx Corp
CYTR
$1K 0.01%
+43
New +$634
MHA
53
DELISTED
MANHATTAN PHARM INC
MHA
$1K 0.01%
+5,366
New +$1K
ASMB icon
54
Assembly Biosciences
ASMB
$531M
$0 ﹤0.01%
+3
New +$470
CRMD icon
55
CorMedix
CRMD
$661M
$0 ﹤0.01%
+51
New +$184
UIS icon
56
Unisys
UIS
$265M
$0 ﹤0.01%
+10
New +$200
WINT
57
DELISTED
Windtree Therapeutics Inc
WINT
$0 ﹤0.01%
+16
New +$394
VRSO
58
DELISTED
VERSO TECHNOLOGIES INC
VRSO
$0 ﹤0.01%
+800
New

Similar funds

Hirtle Callaghan & Co's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Hirtle Callaghan & Co, which disclosed 94 positions worth $8.64M. Its ten largest holdings account for 60% of the portfolio.

Its largest position is Berkshire Hathaway Class A: 10 shares worth $1.69M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, followed by Technology and Consumer Staples.

  • Hirtle Callaghan & Co's largest Q2 2013 buy was Berkshire Hathaway Class A: 10 shares worth $1.69M.
  • Hirtle Callaghan & Co's ten largest holdings make up 60% of its $8.64M portfolio in Q2 2013.
  • Hirtle Callaghan & Co disclosed 94 positions in Q2 2013, its first 13F filing on record.

Based on Hirtle Callaghan & Co's 13F filing for Q2 2013, filed 18 Jul 2013.